Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kathryn C. Zoon currently holds 71,799 shares of Emergent BioSolutions Inc. (EBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kathryn C. Zoon has been a net seller of EBS stock. They have purchased $0 and sold $2.0M worth of shares.
Kathryn C. Zoon's most recent insider trade was on Aug 15, 2025, when they sold 7,086 shares at $8.87 per share.
Kathryn C. Zoon serves as Executive at Emergent BioSolutions Inc. (EBS). They have executed 33 insider transactions totaling $2.0M over their tenure at the company.
Kathryn C. Zoon holds the position of Executive at Emergent BioSolutions Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Kathryn C. Zoon has shown a selling trading pattern, with $0 in total purchases and $2.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kathryn C. Zoon was on May 26, 2020, when they sold $348.3K worth of EBS shares. This transaction involved 4,093 shares at $85.10 per share.
Kathryn C. Zoon currently owns 71,799 shares of Emergent BioSolutions Inc. (EBS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kathryn C. Zoon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kathryn C. Zoon has 33 Form 4 filings on record as an insider at Emergent BioSolutions Inc..
Set alerts for Kathryn C. Zoon and 40,000+ other insiders.